Bluebird Bio
(NQ:
BLUE
)
0.3899
+0.0136 (+3.61%)
Streaming Delayed Price
Updated: 12:44 PM EST, Nov 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bluebird Bio
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
May 20, 2021
Gainers Enveric Biosciences (NASDAQ:ENVB)...
Via
Benzinga
Long-Term Data from Pivotal KarMMa Study Continue to Demonstrate Deep and Durable Responses and Predictable Safety Profile with Bristol Myers Squibb and bluebird bio’s Abecma (idecabtagene vicleucel) in Relapsed or Refractory Multiple Myeloma
May 19, 2021
From
Bristol Myers Squibb
Via
Business Wire
bluebird bio to Present Data from Its Severe Genetic Disease and Oncology Portfolios During the EHA2021 Virtual Congress
May 13, 2021
From
bluebird bio, Inc.
Via
Business Wire
NASDAQ:BLUE Long Term Investor Alert: Investigation of Potential Wrongdoing at Bluebird Bio Inc
May 12, 2021
San Diego, CA -- (SBWIRE) -- 05/12/2021 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors of bluebird bio Inc.
Via
SBWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
bluebird bio Reports First Quarter Financial Results and Highlights Operational Progress
May 05, 2021
From
bluebird bio, Inc.
Via
Business Wire
bluebird bio Announces May Investor Events
May 03, 2021
From
bluebird bio, Inc.
Via
Business Wire
What Investors Need to Know About This $419,500 CAR-T Cancer Treatment
May 01, 2021
Abecma is on the market.
Via
The Motley Fool
Will Vertex's Sickle Cell Gambit Sink bluebird bio's Stock?
May 01, 2021
The competition is starting to heat up, but bluebird is far from finished.
Via
The Motley Fool
bluebird bio Provides Update on Severe Genetic Disease Programs and Business Operations
April 20, 2021
From
bluebird bio, Inc.
Via
Business Wire
Is bluebird bio a Bad News Buy?
April 14, 2021
The biotech has had a rough couple of years.
Via
The Motley Fool
DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
April 13, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
April 12, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
TUESDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
April 09, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE)
April 09, 2021
From
The Law Offices of Frank R. Cruz
Via
Business Wire
TUESDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
April 08, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
TUESDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
April 07, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against bluebird bio, Inc. and Encourages Investors to Contact the Firm
April 06, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.